Avanza Fonder AB Invests $1.37 Million in Avantor, Inc. (NYSE:AVTR)

Avanza Fonder AB purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 64,936 shares of the company’s stock, valued at approximately $1,368,000.

A number of other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. acquired a new stake in shares of Avantor during the third quarter valued at about $49,000. Nisa Investment Advisors LLC increased its holdings in Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after purchasing an additional 835 shares during the last quarter. GAMMA Investing LLC increased its holdings in Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after purchasing an additional 1,285 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Avantor by 278.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock valued at $130,000 after purchasing an additional 3,700 shares in the last quarter. Finally, Quarry LP boosted its stake in shares of Avantor by 4,489.1% during the 2nd quarter. Quarry LP now owns 6,333 shares of the company’s stock valued at $134,000 after buying an additional 6,195 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Price Performance

Shares of NYSE AVTR opened at $22.14 on Friday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The firm has a market capitalization of $15.07 billion, a PE ratio of 48.13, a P/E/G ratio of 3.42 and a beta of 1.28. Avantor, Inc. has a 1-year low of $19.59 and a 1-year high of $28.00. The business’s fifty day moving average price is $21.45 and its two-hundred day moving average price is $23.35.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on AVTR. Wells Fargo & Company dropped their price target on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th. Robert W. Baird reduced their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. Barclays lowered their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Finally, UBS Group reaffirmed a “neutral” rating and set a $25.00 target price (down previously from $29.00) on shares of Avantor in a report on Friday. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $27.38.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.